Aldeyra Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGAldeyra Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 12), showing significant lag compared to the market leaders. Earnings growth of 66% provides fundamental context to the price action. However, price is extended 20% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.75 | +16.84% | ABOVE |
| 50 SMA | $1.71 | +20.18% | ABOVE |
| 100 SMA | $2.84 | -27.87% | BELOW |
| 150 SMA | $3.52 | -41.71% | BELOW |
| 200 SMA | $3.95 | -48.12% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ALDX in an uptrend right now?
ALDX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ALDX overbought or oversold?
ALDX's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.
Is ALDX outperforming the market?
ALDX has a Relative Strength (RS) Rating of 12 out of 99. ALDX is currently lagging the broader market.
Where is ALDX in its 52-week range?
ALDX is trading at $2.05, which is 33% of its 52-week high ($6.18) and 19% above its 52-week low ($1.07).
How volatile is ALDX?
ALDX has a Beta of 1.25 and 52-week volatility of 108%. It's more volatile than the S&P 500 - expect bigger swings.